Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
93.00    -0.50 (-0.53%)
Bid:
91.00
Ask:
95.00
Spread: 4.00 (4.396%)
Market Cap: £108.18m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Relationship Agreement with Brave Bison

21 Apr 2026 07:01

RNS Number : 2072B
System1 Group PLC
21 April 2026
 

 

21 April 2026

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Relationship Agreement with Brave Bison

 

Further to the announcement on 2 March 2026 in relation to Brave Bison Group plc ("Brave Bison") acquiring a 27.85 per cent. shareholding in System1, the Company announces that it has entered into a customary relationship agreement with Brave Bison (the "Relationship Agreement") which includes the opportunity for a representative of Brave Bison to be appointed as an observer to the Company's board of directors (the "Board").

 

The key terms of the Relationship Agreement are as follows:

· Brave Bison has a right to appoint an observer to attend Board meetings subject to the prior approval of the Board;

· Brave Bison shall not take any action that is intended to or has the effect of preventing the Board from operating independently of Brave Bison;

· Brave Bison shall not take any action that would prevent System1 from complying with its obligations under applicable laws including the AIM Rules for Companies, the UK Market Abuse Regulation and the Corporate Governance Code published by the Quoted Companies Alliance;

· All transactions and dealings between the Company and Brave Bison, or any of its associated undertakings, shall be effected on arm's length terms and on a normal commercial basis; and

· The Relationship Agreement contains terms governing the provision of information to Brave Bison by the Company and customary provisions regarding the protection of confidential information.

 

The Relationship Agreement will terminate if Brave Bison and its associated undertakings cease to hold, in aggregate, 17.5 per cent. of the voting rights attaching to the issued ordinary share capital of the Company.

 

Rupert Howell, Non-Executive Chair of System1 commented:

 

"The Board of System1 is committed to acting in the interests of all its shareholders and we welcome Brave Bison as a significant shareholder in the Company. After careful consideration, and in line with its robust governance practices, the Board concluded it to be in the best interests of all shareholders and stakeholders to enter into a suitable agreement with Brave Bison, fostering a constructive and transparent relationship." 

 

Oliver Green, Chairman of Brave Bison commented:

 

"We are pleased to formalise our relationship with System1, and we look forward to working constructively with the Board and management team."

 

For further information, please contact:

 

System1 Group PLC

via Alma

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited (Nominated Adviser & Broker)

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

Singer Capital Markets (Joint Broker) 

Tel: +44 (0) 20 7496 3000 

James Moat / James Fischer

Alma Strategic Communications 

Tel: +44 (0)20 3405 0205

Caroline Forde / Rebecca Sanders-Hewett / Robyn Fisher

System1@almastrategic.com 

 

About System1 Group plc

 

System1 is a marketing decision-making platform business, utilised by some of the world's largest brands, across 81 markets globally. Since 2000, System1 has helped marketers tap into consumers' emotions to predict and improve the commercial impact of ads and ideas. Drawing on the world's largest database of emotional norms, our advertising and idea tests measure emotion to give our customers the most accurate predictions of the business impact of creativity. We 'predict' (provide research results) and work with our customers and 'improve' (provide insight and consultancy on those results) advertising effectiveness, innovation effectiveness and brand effectiveness. 

 

We work for more than 500 customers, including 5 of the top 10 US and 8 of the top 10 UK advertisers. Customers include Pfizer, Amazon, TikTok, Sky, Lego, Pladis and Natura.

 

Further information on the Company can be found at www.system1group.com.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 and as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBIGDSDUDDGLG
Date   Source Headline
19th Jun 20264:26 pmRNSHolding(s) in Company
17th Jun 20264:41 pmRNSResult of Annual General Meeting
17th Jun 20267:00 amRNSAGM Statement
15th Jun 20267:00 amRNSMark Ritson Option Exercise
8th Jun 20265:17 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSProposed Long Term Incentive Plan
27th May 20267:00 amRNSMello Investor Presentation
18th May 20267:00 amRNSAnnual Report, Notice of AGM & Dividend Dates
6th May 20267:00 amRNS-RMajor Contract Win
5th May 20267:00 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSNED Appointment
30th Apr 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSNotice of Results & Investor Presentation
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
6th Mar 20264:56 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20263:30 pmRNSTVR
2nd Mar 20267:10 amRNSStrategic Investment in System1
2nd Feb 20267:00 amRNSMajor Contract Win
29th Jan 202610:12 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSTrading Update
19th Dec 20253:00 pmRNSUpdate on Issue of Equity
12th Dec 20252:58 pmRNSExercise of Options, Issue of Equity and TVR
5th Dec 20254:00 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSResponse to Press Speculation
29th Oct 20257:00 amRNSAppointment of Joint Broker
24th Oct 20255:09 pmRNSResult of General Meeting
24th Oct 20253:00 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSHolding(s) in Company
8th Oct 20252:47 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of GM - Recommendation to Vote Against
1st Oct 202512:42 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSRequisition of General Meeting
25th Sep 202510:10 amRNSExercise of LTIP, Director Dealings and TVR
24th Sep 20253:52 pmRNSShareholder Update
23rd Sep 20257:00 amRNSHolding(s) in Company
22nd Sep 202511:32 amRNSHolding(s) in Company
11th Sep 20257:01 amRNSAcquisition and Trading Update
11th Sep 20257:00 amRNSInterim Results
10th Sep 20253:00 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of Results & Investor Presentation
1st Sep 20259:15 amRNSHolding(s) in Company
4th Aug 202511:34 amRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.